Rapamycin in preventive (very low) doses

Roman V. Kondratov¹, Anna A. Kondratova²

¹Center for Gene Regulation in Health and Diseases, BGES, Cleveland State University, Cleveland, OH 44115; USA
²Department of Molecular Genetics, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195; USA

Received: March 4, 2014Accepted: March 22, 2014Published: March 22, 2014

https://doi.org/http://dx.doi.org/10.18632/aging.100645

Copyright: © 2014 Kondratov et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.